Tenable Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 24, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
10. Stock-Based Compensation
- Stock-Based Compensation
Stock-based compensation expense included in the consolidated statements of operations was as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (in thousands) | 2024 | 2023 | 2022 |
| Cost of revenue | $12,677 | $11,247 | $8,369 |
| Sales and marketing | 62,727 | 61,322 | 49,383 |
| Research and development | 47,656 | 37,225 | 31,499 |
| General and administrative | 40,455 | 35,533 | 31,382 |
| Total stock-based compensation expense | $163,515 | $145,327 | $120,633 |
A summary of the unrecognized stock-based compensation expense related to unvested awards at December 31, 2024 is presented below:
| Unrecognized Stock-Based Compensation Expense (in thousands) | Estimated Weighted Average Period (in years) | |
|---|---|---|
| Restricted stock units ("RSUs") | $273,367 | 2.6 |
| Performance stock units ("PSUs") | 5,522 | 2.8 |
| Restricted stock | 7,136 | 1.3 |
| 2018 Employee Stock Purchase Plan ("2018 ESPP") | 10,744 | 0.9 |
Restricted Stock, RSUs and PSUs
A summary of our restricted stock, RSU and PSU activity is presented below:
| Restricted Stock | RSUs | PSUs | ||||
|---|---|---|---|---|---|---|
| (in thousands, except for per share data) | Numberof Shares | WeightedAverageGrant Date Fair Value | Numberof Shares | WeightedAverageGrant Date Fair Value | Numberof Shares | WeightedAverageGrant Date Fair Value |
| Unvested balance at December 31, 2021 | — | $— | 5,781 | $37.74 | — | $— |
| Granted | — | — | 4,653 | 45.83 | 209 | 44.97 |
| Vested | — | — | (2,510) | 36.47 | — | — |
| Forfeited | — | — | (1,030) | 40.45 | (13) | 44.97 |
| Unvested balance at December 31, 2022 | — | — | 6,894 | 43.26 | 196 | 44.97 |
| Granted | 311 | 45.67 | 4,728 | 43.47 | 188 | 43.24 |
| Performance adjustment(1) | — | — | — | — | 12 | 44.97 |
| Vested | — | — | (3,153) | 41.61 | (91) | 44.97 |
| Forfeited | — | — | (1,126) | 45.14 | (47) | 43.92 |
| Unvested balance at December 31, 2023 | 311 | 45.67 | 7,343 | 43.80 | 258 | 43.90 |
| Granted | — | — | 4,099 | 45.89 | 170 | 47.20 |
| Performance adjustment(1) | — | — | — | — | (10) | 43.24 |
| Vested | (124) | 45.67 | (3,217) | 43.34 | (107) | 43.93 |
| Forfeited | — | — | (1,016) | 45.00 | (11) | 43.95 |
| Unvested balance at December 31, 2024 | 187 | 45.67 | 7,209 | 45.01 | 300 | 45.78 |
(1) Represents adjustments due to the achievement of predefined financial performance targets.
In January 2024, under the evergreen provision in our 2018 Equity Incentive Plan we reserved an additional 5.9 million shares of our common stock. At December 31, 2024, there were 26.1 million shares available for grant under the plan.
In 2023, as part of the acquisition of Ermetic, we issued replacement equity awards, of which $0.5 million was attributable to services performed prior to the acquisition date and allocated to purchase consideration. The remaining fair value was allocated to future services and is being expensed over the remaining service periods as stock-based compensation.
Stock Options
A summary of our stock option activity is presented below:
| (in thousands, except for exercise prices and years) · Numberof Shares · WeightedAverageExercise Price · Weighted-Average Remaining Contractual Term(in years) · Aggregate Intrinsic Value | ||||||
|---|---|---|---|---|---|---|
| Outstanding at December 31, 2021 | 6,731 | $9.21 | 5.5 | $308,677 | ||
| Exercised | (1,174) | 9.98 | 47,880 | |||
| Forfeited/canceled | (72) | 16.15 | ||||
| Outstanding at December 31, 2022 | 5,485 | 8.96 | 4.5 | 160,135 | ||
| Exercised | (387) | 9.05 | 13,364 | |||
| Forfeited/canceled | (3) | 10.97 | ||||
| Outstanding at December 31, 2023 | 5,095 | 8.95 | 3.5 | 189,108 | ||
| Exercised | (1,044) | 7.72 | 38,831 | |||
| Forfeited/canceled | — | — | ||||
| Outstanding and exercisable at December 31, 2024 | 4,051 | 9.26 | 2.6 | 122,024 | ||
Stock options were last granted in 2018. Stock options granted under our stock incentive plans have a maximum term often years, generally vest over a period ofthree tofour years, and the exercise price cannot be less than the fair market value on the date of grant.
Estimating the fair value of ESPP purchase rights using the Black-Scholes option-pricing model requires assumptions as to the fair value of common stock, expected term, expected volatility, the risk-free interest rate and the expected dividend yield.
Fair Value of Common Stock. We use the market price of our common stock at the date of grant.
Expected Term. We use the actual purchase periods as the expected term in the 2018 ESPP.
Expected Volatility. Volatility is a measure of the amount by which a financial variable, such as a share price, has fluctuated (historical volatility) or is expected to fluctuate (expected volatility) during a period. In 2021, we began using the volatility of our common stock to calculate expected volatility. Prior to 2021, we identified several public entities of similar size, complexity, and stage of development and estimated our volatility based on the volatility of the common stock of these companies.
Risk-Free Interest Rate. This is the U.S. Treasury rate, having a term that most closely resembles the expected life of the stock option.
Expected Dividend Yield. We have never declared or paid dividends and have no plans to do so in the foreseeable future.
2018 Employee Stock Purchase Plan
Under our 2018 ESPP, employees may set aside up to 15% of their gross earnings, on an after-tax basis, to purchase our common stock at a discounted price, which is calculated at 85% of the lower of the fair market value of our common stock on the first day of an offering or on the date of purchase. The 2018 ESPP permits offerings up to 27 months in duration, with one or more purchase periods in each offering. Additionally, in cases where the fair market value of a share of our common stock on the first day of a new purchase period within an offering is less than or equal to the fair market value of a share of our common stock at the beginning of the offering, that offering will be terminated and participants will be automatically enrolled in a new offering with a new 24-month duration and purchase periods everysix months.
A summary of our ESPP activity is presented below:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Shares of common stock purchased | 498,890 | 506,390 | 442,629 |
| Weighted average price | $32.60 | $32.04 | $33.42 |
| Cash proceeds (in thousands) | $16,262 | $16,224 | $14,791 |
At December 31, 2024 and 2023 there were $6.9 million and $7.9 million, respectively, of employee contributions to the 2018 ESPP included in accrued compensation.
The fair value of the 2018 ESPP purchase rights was estimated on the offering or modification dates using a Black-Scholes option-pricing model and the following assumptions:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Expected term (in years) | 0.5 — 2.0 | 0.5 — 2.0 | 0.5 — 2.0 |
| Expected volatility | 31.9% — 51.4% | 46.9% — 58.1% | 42.8% — 61.0% |
| Risk-free interest rate | 3.8% — 5.1% | 4.8% — 5.4% | 0.1% — 3.4% |
| Expected dividend yield | — | — | — |
Under the evergreen provision in our 2018 ESPP, in January 2024 we reserved an additional 1.8 million shares of our common stock. At December 31, 2024, there were 10.0 million shares reserved for issuance under the 2018 ESPP.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.